Medically reviewed by Drugs.com. Last updated on Aug 5, 2020.
Generic name: RISEDRONATE SODIUM HEMI-PENTAHYDRATE 30.1mg, RISEDRONATE SODIUM MONOHYDRATE 4.9mg
Dosage form: tablet, delayed release
2.1 Treatment of Postmenopausal Osteoporosis
The recommended regimen is:
- one 35 mg delayed-release tablet orally, taken once-a-week
2.2 Important Administration Instructions
Instruct patients to do the following:
- Take Atelvia in the morning immediately following breakfast. Atelvia should be taken immediately following breakfast and not under fasting conditions because of a higher risk of abdominal pain if taken before breakfast when fasting.
- Swallow Atelvia whole while in an upright position and with at least 4 ounces of plain water to facilitate delivery to the stomach. Avoid lying down for 30 minutes after taking the medication [see Warnings and Precautions (5.2)].
- Do not chew, cut, or crush Atelvia tablets.
2.3 Recommendations for Calcium and Vitamin D Supplementation
Instruct patients to take supplemental calcium and vitamin D if dietary intake is inadequate [see Warnings and Precautions (5.3)] and to take calcium supplements, antacids, magnesium-based supplements or laxatives, and iron preparations at a different time of the day as they interfere with the absorption of Atelvia.
Frequently asked questions
More about Atelvia (risedronate)
- Side Effects
- During Pregnancy or Breastfeeding
- Patient Tips
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 3 Reviews
- Generic Availability
- Drug class: bisphosphonates
- FDA Approval History
- Other brands
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.